Table 2.
Prevalence and incidence of COVID-19 in coeliac patients compared to the general population of Lombardy region
| Studied population | Prevalence (95% CI) | P-value (Fisher’s exact) | Incidence/1000 PM (95% CI) | P-value (Fisher’s exact) | OR (95% CI) |
|---|---|---|---|---|---|
| COVID-19 in all coeliac patients | 2.78% (95% CI 0.98–4.58%) | - | 8.15 (4.24–15.66) | - | - |
| COVID-19 in coeliac patients residing in Lombardy | 3.21% (95% CI 1.14–5.29%) | - | 9.46 (4.92–18.18) | - | - |
| COVID-19 diagnosed by nasal swab in coeliac patients residing in Lombardy | 1.79% (95% CI 0.22–3.35) | 0.11 | 5.26 (2.19–12.63) | 0.10 | 2.00 |
| (0.84–4.84), P = 0.12 | |||||
| COVID-19 diagnosed by nasal swab in the general Lombardy populationa | 0.90 % (95% CI 0.89–0.90) | 2.57 (2.56–2.59) |
a
Prevalence and incidence were calculated from data provided by the Italian National Institute of Health (Istituto Superiore di Sanità) and the Lombardy regional government [18,19]. As of 5 June 2020, cases of COVID-19 ascertained by nasal swab in Lombardy were 90 633 and the population of Lombardy was 10 060 574.
95% CI, 95% confidence interval; OR, odds ratio; PM, person-months.